Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rituximab | 2 | 2021 | 155 | 0.830 |
Why?
|
| Wilms Tumor | 1 | 2023 | 111 | 0.770 |
Why?
|
| Injection Site Reaction | 1 | 2021 | 7 | 0.740 |
Why?
|
| Anaphylaxis | 1 | 2021 | 79 | 0.670 |
Why?
|
| Immunologic Factors | 1 | 2021 | 179 | 0.660 |
Why?
|
| Neutropenia | 1 | 2021 | 202 | 0.650 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 432 | 0.610 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2017 | 13 | 0.580 |
Why?
|
| Sarcoma, Kaposi | 3 | 2023 | 120 | 0.510 |
Why?
|
| Rotavirus Vaccines | 1 | 2015 | 71 | 0.490 |
Why?
|
| Rotavirus Infections | 1 | 2015 | 353 | 0.410 |
Why?
|
| Caliciviridae Infections | 1 | 2015 | 323 | 0.410 |
Why?
|
| Rotavirus | 1 | 2015 | 497 | 0.400 |
Why?
|
| Norovirus | 1 | 2015 | 311 | 0.390 |
Why?
|
| Encephalitis | 2 | 2023 | 109 | 0.360 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 805 | 0.350 |
Why?
|
| Malawi | 4 | 2023 | 389 | 0.320 |
Why?
|
| HIV Infections | 4 | 2023 | 1856 | 0.290 |
Why?
|
| Odds Ratio | 2 | 2021 | 1244 | 0.240 |
Why?
|
| Infant | 5 | 2023 | 12357 | 0.240 |
Why?
|
| Kasabach-Merritt Syndrome | 1 | 2023 | 16 | 0.210 |
Why?
|
| Nephrectomy | 1 | 2023 | 172 | 0.190 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2021 | 18 | 0.190 |
Why?
|
| Long Term Adverse Effects | 1 | 2021 | 12 | 0.190 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 39 | 0.180 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 115 | 0.180 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2021 | 31 | 0.180 |
Why?
|
| Nephrotic Syndrome | 1 | 2021 | 47 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2021 | 13884 | 0.180 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 1305 | 0.180 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 49 | 0.180 |
Why?
|
| Child | 7 | 2023 | 24231 | 0.170 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 141 | 0.170 |
Why?
|
| Herpesvirus 8, Human | 1 | 2019 | 49 | 0.170 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 1237 | 0.160 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 1213 | 0.160 |
Why?
|
| Anemia | 1 | 2023 | 340 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 175 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 518 | 0.150 |
Why?
|
| Lymphoma | 1 | 2021 | 324 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 335 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2023 | 16037 | 0.140 |
Why?
|
| Adolescent | 5 | 2023 | 19104 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1232 | 0.130 |
Why?
|
| Bolivia | 1 | 2015 | 14 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 532 | 0.130 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2018 | 221 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 372 | 0.120 |
Why?
|
| Urban Population | 1 | 2015 | 221 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 1282 | 0.110 |
Why?
|
| Humans | 10 | 2023 | 123092 | 0.100 |
Why?
|
| Gastroenteritis | 1 | 2015 | 341 | 0.100 |
Why?
|
| Hospitals | 1 | 2015 | 396 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2846 | 0.100 |
Why?
|
| Male | 6 | 2023 | 60091 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1584 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2021 | 4703 | 0.090 |
Why?
|
| Female | 6 | 2023 | 65538 | 0.090 |
Why?
|
| Time Factors | 1 | 2021 | 6222 | 0.090 |
Why?
|
| Genotype | 1 | 2015 | 2535 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 1138 | 0.080 |
Why?
|
| Prevalence | 1 | 2015 | 2404 | 0.080 |
Why?
|
| Young Adult | 1 | 2021 | 8839 | 0.070 |
Why?
|
| Tanzania | 1 | 2023 | 67 | 0.050 |
Why?
|
| Lymphadenopathy | 1 | 2019 | 29 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 464 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 393 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 1728 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 4227 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 29018 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6027 | 0.020 |
Why?
|